Mortality and mode of dialysis: meta-analysis and systematic review

Abstract Background The global use of kidney replacement therapy (KRT) has increased, mirroring the incidence of acute kidney injury and chronic kidney disease. Despite its growing clinical usage, patient outcomes with KRT modalities remain controversial. In this meta-analysis, we sought to compare...

Full description

Bibliographic Details
Main Authors: Subhash Chander, Sindhu Luhana, FNU Sadarat, Om Parkash, Zubair Rahaman, Hong Yu Wang, FNU Kiran, Abhi Chand Lohana, FNU Sapna, Roopa Kumari
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Nephrology
Subjects:
Online Access:https://doi.org/10.1186/s12882-023-03435-4
_version_ 1827388713118728192
author Subhash Chander
Sindhu Luhana
FNU Sadarat
Om Parkash
Zubair Rahaman
Hong Yu Wang
FNU Kiran
Abhi Chand Lohana
FNU Sapna
Roopa Kumari
author_facet Subhash Chander
Sindhu Luhana
FNU Sadarat
Om Parkash
Zubair Rahaman
Hong Yu Wang
FNU Kiran
Abhi Chand Lohana
FNU Sapna
Roopa Kumari
author_sort Subhash Chander
collection DOAJ
description Abstract Background The global use of kidney replacement therapy (KRT) has increased, mirroring the incidence of acute kidney injury and chronic kidney disease. Despite its growing clinical usage, patient outcomes with KRT modalities remain controversial. In this meta-analysis, we sought to compare the mortality outcomes of patients with any kidney disease requiring peritoneal dialysis (PD), hemodialysis (HD), or continuous renal replacement therapy (CRRT). Methods The investigation was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). PubMed (MEDLINE), Cochrane Library, and Embase databases were screened for randomized trials and observational studies comparing mortality rates with different KRT modalities in patients with acute or chronic kidney failure. A random-effects model was applied to compute the risk ratio (RR) and 95% confidence intervals (95%CI) with CRRT vs. HD, CRRT vs. PD, and HD vs. PD. Heterogeneity was assessed using I 2 statistics, and sensitivity using leave-one-out analysis. Results Fifteen eligible studies were identified, allowing comparisons of mortality risk with different dialytic modalities. The relative risk was non-significant in CRRT vs. PD [RR = 0.95, (95%CI 0.53, 1.73), p = 0.92 from 4 studies] and HD vs. CRRT [RR = 1.10, (95%CI 0.95, 1.27), p = 0.21 from five studies] comparisons. The findings remained unchanged in the leave-one-out sensitivity analysis. Although PD was associated with lower mortality risk than HD [RR = 0.78, (95%CI 0.62, 0.97), p = 0.03], the significance was lost with the exclusion of 4 out of 5 included studies. Conclusion The current evidence indicates that while patients receiving CRRT may have similar mortality risks compared to those receiving HD or PD, PD may be associated with lower mortality risk compared to HD. However, high heterogeneity among the included studies limits the generalizability of our findings. High-quality studies comparing mortality outcomes with different dialytic modalities in CKD are necessary for a more robust safety and efficacy evaluation.
first_indexed 2024-03-08T16:22:53Z
format Article
id doaj.art-f127addfd20e455bbda3c994cf681ee5
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-03-08T16:22:53Z
publishDate 2024-01-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-f127addfd20e455bbda3c994cf681ee52024-01-07T12:15:20ZengBMCBMC Nephrology1471-23692024-01-0125111310.1186/s12882-023-03435-4Mortality and mode of dialysis: meta-analysis and systematic reviewSubhash Chander0Sindhu Luhana1FNU Sadarat2Om Parkash3Zubair Rahaman4Hong Yu Wang5FNU Kiran6Abhi Chand Lohana7FNU Sapna8Roopa Kumari9Department of Medicine, Icahn School of Medicine at Mount SinaiDepartment of Medicine, AGA khan University HospitalDepartment of Medicine, University at BuffaloDepartment of Medicine, Montefiore Medical CentreDepartment of Medicine, University at BuffaloDepartment of Medicine, Icahn School of Medicine at Mount SinaiDepartment of Pathology, Northwell Health Staten Island University HospitalDepartment of Medicine, WVU, Camden Clark Medical CentreDepartment of Pathology, Albert Einstein School of Medicine, Montefiore Medical CentreDepartment of Pathology, Icahn School of Medicine at Mount SinaiAbstract Background The global use of kidney replacement therapy (KRT) has increased, mirroring the incidence of acute kidney injury and chronic kidney disease. Despite its growing clinical usage, patient outcomes with KRT modalities remain controversial. In this meta-analysis, we sought to compare the mortality outcomes of patients with any kidney disease requiring peritoneal dialysis (PD), hemodialysis (HD), or continuous renal replacement therapy (CRRT). Methods The investigation was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). PubMed (MEDLINE), Cochrane Library, and Embase databases were screened for randomized trials and observational studies comparing mortality rates with different KRT modalities in patients with acute or chronic kidney failure. A random-effects model was applied to compute the risk ratio (RR) and 95% confidence intervals (95%CI) with CRRT vs. HD, CRRT vs. PD, and HD vs. PD. Heterogeneity was assessed using I 2 statistics, and sensitivity using leave-one-out analysis. Results Fifteen eligible studies were identified, allowing comparisons of mortality risk with different dialytic modalities. The relative risk was non-significant in CRRT vs. PD [RR = 0.95, (95%CI 0.53, 1.73), p = 0.92 from 4 studies] and HD vs. CRRT [RR = 1.10, (95%CI 0.95, 1.27), p = 0.21 from five studies] comparisons. The findings remained unchanged in the leave-one-out sensitivity analysis. Although PD was associated with lower mortality risk than HD [RR = 0.78, (95%CI 0.62, 0.97), p = 0.03], the significance was lost with the exclusion of 4 out of 5 included studies. Conclusion The current evidence indicates that while patients receiving CRRT may have similar mortality risks compared to those receiving HD or PD, PD may be associated with lower mortality risk compared to HD. However, high heterogeneity among the included studies limits the generalizability of our findings. High-quality studies comparing mortality outcomes with different dialytic modalities in CKD are necessary for a more robust safety and efficacy evaluation.https://doi.org/10.1186/s12882-023-03435-4HemodialysisPeritoneal dialysisCRRTContinuous kidney replacement therapy
spellingShingle Subhash Chander
Sindhu Luhana
FNU Sadarat
Om Parkash
Zubair Rahaman
Hong Yu Wang
FNU Kiran
Abhi Chand Lohana
FNU Sapna
Roopa Kumari
Mortality and mode of dialysis: meta-analysis and systematic review
BMC Nephrology
Hemodialysis
Peritoneal dialysis
CRRT
Continuous kidney replacement therapy
title Mortality and mode of dialysis: meta-analysis and systematic review
title_full Mortality and mode of dialysis: meta-analysis and systematic review
title_fullStr Mortality and mode of dialysis: meta-analysis and systematic review
title_full_unstemmed Mortality and mode of dialysis: meta-analysis and systematic review
title_short Mortality and mode of dialysis: meta-analysis and systematic review
title_sort mortality and mode of dialysis meta analysis and systematic review
topic Hemodialysis
Peritoneal dialysis
CRRT
Continuous kidney replacement therapy
url https://doi.org/10.1186/s12882-023-03435-4
work_keys_str_mv AT subhashchander mortalityandmodeofdialysismetaanalysisandsystematicreview
AT sindhuluhana mortalityandmodeofdialysismetaanalysisandsystematicreview
AT fnusadarat mortalityandmodeofdialysismetaanalysisandsystematicreview
AT omparkash mortalityandmodeofdialysismetaanalysisandsystematicreview
AT zubairrahaman mortalityandmodeofdialysismetaanalysisandsystematicreview
AT hongyuwang mortalityandmodeofdialysismetaanalysisandsystematicreview
AT fnukiran mortalityandmodeofdialysismetaanalysisandsystematicreview
AT abhichandlohana mortalityandmodeofdialysismetaanalysisandsystematicreview
AT fnusapna mortalityandmodeofdialysismetaanalysisandsystematicreview
AT roopakumari mortalityandmodeofdialysismetaanalysisandsystematicreview